The United States Patent and Trademark Office (USPTO) has issued patent US12582342B2 to Analytics for Life Inc. This patent covers a method and system for assessing pulmonary hypertension by employing phase space tomography and machine learning. The technology generates computed phase-space tomographic images and mathematical features to represent the dynamics of cardiac systems, which can then be used by physicians to aid in disease assessment. Specifically, the patent describes using these tomographic images as input for a trained neural network classifier designed to detect the presence or absence of pulmonary hypertension, including pulmonary arterial hypertension.

This patent grant represents a new technological development in medical diagnostics. While patents themselves are not regulations, they can influence the development and adoption of medical technologies. Healthcare providers and medical device manufacturers should be aware of this patented technology, as it may impact future diagnostic tools and treatment pathways for pulmonary hypertension. There are no immediate compliance obligations arising from this patent grant; however, companies developing similar technologies should be mindful of existing intellectual property rights.